AI drug discovery company
Antiverse
Data as of .
Company facts
-
Founded
2017
-
Headquarters
United Kingdom (Cardiff)
Latest funding round
- Round
- Series A
- Date
- Mar 3, 2026
- Amount
- $9.3M
- Lead investor
- Soulmates Ventures
Recent news
-
Raises a $9.3M Series A and signs a research agreement with the Cystic Fibrosis Foundation
Confirmed means the company, a partner or a filing said it. Reported means a third party said it. This section sits outside the Pharma AI Tracker.
Spot an error? Tell me and I'll fix it.